Aspyra becomes IMIX DR reseller

Aspyra has entered into a non-exclusive reseller agreement with IMIX Americas, allowing the former to resell and promote IMIX’s digital radiography (DR) technology product line in the United States to new and existing Aspyra PACS customers.

IMIX is a manufacturer of DR systems for diagnostic use in hospitals, clinics, imaging centers and orthopedic group practices.

Aspyra of Calabassas, Calif., said it will resell the IMIX DR technology solutions with its AccessNET and AccessMED PACS solutions.

The 18-month national reseller agreement became effective Oct. 15, according to both companies.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.